SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
SUDDEN CARDIAC FAILURE, INFANTILE
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
SUDDEN CARDIAC FAILURE, INFANTILE
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
SUDDEN CARDIAC FAILURE, INFANTILE
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
SUDDEN CARDIAC FAILURE, INFANTILE
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myocarditis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myocardial fibrosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Bradycardia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Depletion of mitochondrial DNA
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We sequenced the PPA2 gene in 13 patients with mitochondrial DNA depletion syndromes (MDS) of unknown cause to determine if mutations in the PPA2 gene of these patients were associated with this disease.
|
16300924 |
2006 |
SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Sudden Cardiac Death Due to Deficiency of the Mitochondrial Inorganic Pyrophosphatase PPA2.
|
27523597 |
2016 |
SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Sudden Cardiac Death Due to Deficiency of the Mitochondrial Inorganic Pyrophosphatase PPA2.
|
27523597 |
2016 |
SUDDEN CARDIAC FAILURE, INFANTILE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Sudden Cardiac Death Due to Deficiency of the Mitochondrial Inorganic Pyrophosphatase PPA2.
|
27523597 |
2016 |
SUDDEN CARDIAC FAILURE, INFANTILE
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Sudden Cardiac Death Due to Deficiency of the Mitochondrial Inorganic Pyrophosphatase PPA2.
|
27523597 |
2016 |
Mitochondrial Diseases
|
0.020 |
GeneticVariation
|
group |
BEFREE |
These individuals show a range of severity, indicating that PPA2 mutations may cause a spectrum of mitochondrial disease phenotypes.
|
27523597 |
2016 |
Cardiomyopathies
|
0.020 |
Biomarker
|
group |
BEFREE |
These findings confirm the pathogenicity of PPA2 mutations and suggest that PPA2 is a cardiomyopathy-associated protein, which has a greater physiological importance in mitochondrial function than previously recognized.
|
27523597 |
2016 |
SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic PPA2 Mutations Cause Sudden Unexpected Cardiac Arrest in Infancy.
|
27523598 |
2016 |
SUDDEN CARDIAC FAILURE, INFANTILE
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic PPA2 Mutations Cause Sudden Unexpected Cardiac Arrest in Infancy.
|
27523598 |
2016 |
SUDDEN CARDIAC FAILURE, INFANTILE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Biallelic PPA2 Mutations Cause Sudden Unexpected Cardiac Arrest in Infancy.
|
27523598 |
2016 |
Mitochondrial Diseases
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Altogether these data demonstrate that PPA2 is an essential gene in yeast and that biallelic mutations in PPA2 cause a mitochondrial disease leading to sudden cardiac arrest in infants.
|
27523598 |
2016 |
Cardiac Arrest
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Biallelic PPA2 Mutations Cause Sudden Unexpected Cardiac Arrest in Infancy.
|
27523598 |
2016 |
Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Other changes were specific for adenomas (PPA1 and PPA2 up-regulation; KCTD12 downregulation) or adenocarcinoma (ANP32B, G6PD, RCN1, and SET up-regulation; downregulated AKR1B1, APEX1, and PPA1).
|
28062797 |
2017 |
Breast Carcinoma
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Association analysis identifies 65 new breast cancer risk loci.
|
29059683 |
2017 |
Intelligence
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence.
|
29326435 |
2019 |